BGM
BGM Group Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$0.29
+0.71%Institutional positioning
13F filings over the trailing two quarters
New 8Increased 3Reduced 3Sold out 14
| Filer | Action | Shares | Filed |
|---|---|---|---|
| HRT FINANCIAL LP | New Position | 48,174 | May 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 46,961 | May 15, 2026 |
| STATE STREET CORP | Reduced | 46,532 | May 15, 2026 |
| TWO SIGMA SECURITIES, LLC | New Position | 16,075 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New Position | 15,737 | May 15, 2026 |
| XTX TOPCO LTD | New Position | 11,437 | May 15, 2026 |
| GSA CAPITAL PARTNERS LLP | New Position | 10,197 | May 8, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | Increased | 8,214 | May 15, 2026 |
| ROYAL BANK OF CANADA | Increased | 2,006 | May 15, 2026 |
| JPMORGAN CHASE & CO | Increased | 1,983 | May 13, 2026 |
| UBS GROUP AG | Reduced | 1,952 | May 5, 2026 |
| MORGAN STANLEY | New Position | 200 | May 15, 2026 |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | New Position | 5 | May 14, 2026 |
| SBI SECURITIES CO., LTD. | New Position | 3 | Apr 28, 2026 |
| Rockefeller Capital Management L.P. | Sold Out | 0 | May 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings